NOV 20, 2018 7:00 AM PST

COLD-PCR technology: current status and application in liquid biopsies for cancer and prenatal diagnosis

Sponsored by: Perkin Elmer
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Professor and Director of the Medical Physics & Biophysics division in Radiation Oncology at Dana Farber Cancer Institute and Brigham and Women's Hospitals, Harvard Medical School
    Biography
      Dr. Makrigiorgos is a Professor and Director of the Medical Physics & Biophysics division in Radiation Oncology at Dana Farber Cancer Institute and Brigham and Women's Hospitals, Harvard Medical School. He is as ABR-certified radiation oncology physicist and he also directs his DNA technology laboratory and a radiation pre-clinical facility. His research interests include the development of novel DNA technologies for molecular diagnostics in Oncology and the detection of circulating cancer biomarkers. Funded continuously by NIH over the last 25 years, he invented several new techniques for molecular diagnostics, including Balanced-PCR, COLD-PCR and NaME-PrO. He is a Member of the Editorial Board of Clinical Chemistry and has published over 150 articles in journals including Nature Medicine, Nature Biotechnology, Nucleic Acid Research and Clinical Chemistry. He received his undergraduate degree in Physics from the University of Athens, Greece, his PhD in Medical Physics from the University of Leeds, UK and his postdoctoral training in radiation biology from Harvard Medical School, Boston.

    Abstract

    DATE: November 20, 2018
    TIME: 07:00 PST

    Since its original development (2008) COLD-PCR has been used by several groups for increasing the sensitivity of mutation detection in different settings including cancer diagnostics and prenatal screening. This webinar will review the principle and basic improvements in the technology over the years and will describe envisioned clinical applications in liquid biopsies.

    Learning Objectives:

    • Learn about COLD-PCR principles
    • Understand COLD-PCR application in DNA diagnostics
    • Understand the comparison with other technologies

    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources